Is the Use of Biologic Additions Necessary to Optimize Periodontal Regenerative Efforts

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical advances in periodontics

• Publication date

  2013-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1902/CAP.2012.120090
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Enamel matrix derivative, alone or associated with a synthetic bone substitute, in the treatment of 1- to 2-wall periodontal defects.

  2013cited by this paper
• Platelet-derived growth factor promotes periodontal regeneration in localized osseous defects: 36-month extension results from a randomized, controlled, double-masked clinical trial.

  2013cited by this paper
• PDGF Promotes Periodontal Regeneration in Localized Osseous Defects: 36 Month Extension Results from a Randomized, Controlled, Double-masked Clinical Trial.

  2012cited by this paper
• Periodontal regeneration with enamel matrix derivative in reconstructive periodontal therapy: a systematic review.

  2012cited by this paper
• Human buccal plate extraction socket regeneration with recombinant human platelet-derived growth factor BB or enamel matrix derivative.

  2011cited by this paper
• Comparative study of DFDBA in combination with enamel matrix derivative versus DFDBA alone for treatment of periodontal intrabony defects at 12 months post-surgery

  2011cited by this paper
• Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects.

  2011cited by this paper
• A retrospective consecutive case series using mineralized allograft combined with recombinant human platelet-derived growth factor BB to treat moderate to severe osseous lesions.

  2011cited by this paper
• Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects.

  2009cited by this paper
• Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.

  2009cited by this paper
• Non-bioabsorbable vs. bioabsorbable membrane: assessment of their clinical efficacy in guided tissue regeneration technique. A systematic review.

  2009cited by this paper
• Recombinant human platelet-derived growth factor: biology and clinical applications.

  2008cited by this paper
• Clinical evaluation of demineralized freeze-dried bone allograft with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans.

  2008cited by this paper
• Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration.

  2008cited by this paper
• The Effect of Enamel Matrix Derivative (Emdogain®) on Bone Formation: A Systematic Review

  2008cited by this paper
• Human histologic and clinical evaluation of recombinant human platelet-derived growth factor and beta-tricalcium phosphate for the treatment of periodontal intraosseous defects.

  2008cited by this paper
• In vitro effects of enamel matrix derivative on microvascular cells.

  2007cited by this paper
• Clinical results using recombinant human platelet-derived growth factor and mineralized freeze-dried bone allograft in periodontal defects.

  2007cited by this paper
• ‘ Histologic evaluation of mineralized and demineralized freeze-dried bone allograft for ridge and sinus augmentations

  2005cited by this paper
• Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial.

  2005cited by this paper
• A multicenter study evaluating the sensitization potential of enamel matrix derivative after treatment of two infrabony defects.

  2004cited by this paper
• Growth and amelogenin-like factors in periodontal wound healing. A systematic review.

  2003cited by this paper
• Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone.

  2003cited by this paper
• The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review.

  2003cited by this paper
• Periodontal regeneration in human Class II furcations using purified recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with bone allograft.

  2003cited by this paper
• Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects in humans.

  2002cited by this paper
• Periodontal regeneration following use of ABM/P-1 5: a case report.

  2002cited by this paper
• Thirty-six month follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) bone replacement grafts in human infrabony defects. I. Clinical findings.

  2002cited by this paper
• Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.

  2002cited by this paper
• A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.

  2002cited by this paper
• Effects of enamel matrix derivative on gene expression of primary osteoblasts.

  2001cited by this paper
• The putative collagen binding peptide hastens periodontal ligament cell attachment to bone replacement graft materials.

  2001cited by this paper
• Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series.

  2000cited by this paper
• Enamel matrix-derived protein stimulates attachment of periodontal ligament fibroblasts and enhances alkaline phosphatase activity and transforming growth factor beta1 release of periodontal ligament and gingival fibroblasts.

  2000cited by this paper
• Porcine fetal enamel matrix derivative enhances bone formation induced by demineralized freeze dried bone allograft in vivo.

  2000cited by this paper
• A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans.

  2000cited by this paper
• Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report.

  1999cited by this paper
• Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results.

  1998cited by this paper
• In vitro studies on periodontal ligament cells and enamel matrix derivative.

  1997cited by this paper
• Fate of demineralized freeze-dried bone allografts in human intrabony defects.

  1996cited by this paper
• Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation.

  1996cited by this paper
• Commercially-prepared allograft material has biological activity in vitro.

  1995cited by this paper
• External root resorption.

  1994cited by this paper
• Long-term assessment of combined osseous composite grafting, root conditioning, and guided tissue regeneration.

  1993cited by this paper
• HIV inactivation in a bone allograft.

  1992cited by this paper
• Histologic comparison of regeneration in human intrabony defects when osteogenin is combined with demineralized freeze-dried bone allograft and with purified bovine collagen.

  1991cited by this paper
• A comparison of freeze-dried bone allograft and demineralized freeze-dried bone allograft in human periodontal osseous defects.

  1989cited by this paper
• Histologic evaluation of new attachment apparatus formation in humans. Part II.

  1989cited by this paper
• Combined Osseous Composite Grafting, Root Conditioning, and Guided Tissue Regeneration

  1988cited by this paper
• Decalcified freeze-dried bone allograft as an implant material in human periodontal defects.

  1984cited by this paper
• Clinical evaluation of freeze-dried bone allografts in periodontal osseous defects. Part III. Composite freeze-dried bone allografts with and without autogenous bone grafts.

  1983cited by this paper
• A six-month clinical evaluation of decalcified freeze-dried bone allografts in periodontal osseous defects.

  1982cited by this paper
• Comparison of bone graft materials. Part II. New bone formation with autografts and allografts: a histological evaluation.

  1981cited by this paper
• Comparison of bone graft materials. Part I. New bone formation with autografts and allografts determined by Strontium-85.

  1981cited by this paper
• The induction of new bone and cementum formation. IV. Microscopic examination of the periodontium following human bone and marrow allograft, autograft and nongraft periodontal regenerative procedures.

  1978cited by this paper
• Osseous autografts. III. Comparison of osseous coagulum-bone blend implants with open curetage.

  1976cited by this paper
• Clinical evaluation of freeze-dried bone allografts in periodontal osseous defects.

  1976cited by this paper
• A Clinical and Histological Evaluation of Autogenous Iliac Bone Grafts in Humans Part II. External Root Resorption

  1973cited by this paper
• A Clinical and Histological Evaluation of Autogenous Iliac Bone Grafts in Humans: Part I. Wound Healing 2 to 8 Months

  1973cited by this paper
• Human allografts of iliac cancellous bone and marrow in periodontal osseous defects. II. Clinical observations.

  1972cited by this paper
• Iliac transplants in periodontal therapy.

  1970cited by this paper
• Eradication of bifurcation defects utilizing frozen autogenous hip marrow implants.

  1967cited by this paper
• Bone formation by fresh and frozen transplants of bone, bone marrow and periosteum.

  1947cited by this paper

• Comparative evaluation of platelet rich fibrin matrix (PRFM) membrane and collagen membrane with demineralized freeze-dried bone allograft (DFDBA) in the treatment of mandibular class II furcation defects: A randomized controlled trial

  2023cites this paper